Shuangping Guo

2.3k total citations
50 papers, 855 citations indexed

About

Shuangping Guo is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Shuangping Guo has authored 50 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Pathology and Forensic Medicine and 13 papers in Oncology. Recurrent topics in Shuangping Guo's work include Lymphoma Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Shuangping Guo is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Shuangping Guo collaborates with scholars based in China, United States and United Kingdom. Shuangping Guo's co-authors include Dengfeng Cao, Robert W. Allan, Yan Peng, Kyle Molberg, Yingmei Wang, Zhe Wang, Li Wang, Joseph Rohr, Linni Fan and Jing Zhang and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Shuangping Guo

49 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuangping Guo China 16 382 197 190 189 188 50 855
Eveline J. Kamping Netherlands 14 610 1.6× 168 0.9× 145 0.8× 188 1.0× 191 1.0× 23 1.2k
Sung‐Im Do South Korea 16 399 1.0× 127 0.6× 145 0.8× 175 0.9× 340 1.8× 84 913
Atif Ahmed United States 17 328 0.9× 157 0.8× 187 1.0× 302 1.6× 188 1.0× 95 983
Perkins Mukunyadzi United States 18 328 0.9× 90 0.5× 260 1.4× 185 1.0× 267 1.4× 33 872
Younghye Kim South Korea 13 247 0.6× 180 0.9× 242 1.3× 133 0.7× 251 1.3× 30 817
Pierre Heimann Belgium 16 543 1.4× 180 0.9× 158 0.8× 224 1.2× 335 1.8× 49 1.2k
Alessia Caleo Italy 15 271 0.7× 178 0.9× 227 1.2× 139 0.7× 310 1.6× 38 950
Mervi Aavikko Finland 15 352 0.9× 203 1.0× 77 0.4× 209 1.1× 230 1.2× 27 1.3k
Alessandra Bisagni Italy 16 172 0.5× 134 0.7× 106 0.6× 259 1.4× 285 1.5× 51 765
Lan L. Gellert United States 17 409 1.1× 186 0.9× 329 1.7× 191 1.0× 275 1.5× 30 959

Countries citing papers authored by Shuangping Guo

Since Specialization
Citations

This map shows the geographic impact of Shuangping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangping Guo more than expected).

Fields of papers citing papers by Shuangping Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangping Guo. The network helps show where Shuangping Guo may publish in the future.

Co-authorship network of co-authors of Shuangping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangping Guo. A scholar is included among the top collaborators of Shuangping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangping Guo. Shuangping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kaijing, Jie Wei, Jing Ma, et al.. (2022). Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth. Cancer Letters. 544. 215812–215812. 5 indexed citations
2.
Wang, Kaijing, Jia Chai, Jie Wei, et al.. (2021). TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer. Pathology - Research and Practice. 226. 153603–153603. 3 indexed citations
3.
Ma, Shirong, Danhui Zhao, Yixiong Liu, et al.. (2021). Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands. Histopathology. 79(6). 1030–1039. 10 indexed citations
4.
Guo, Shuangping, Yingmei Wang, Joseph Rohr, Shang Li, & Jing Ma. (2020). p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma. Journal of Clinical Pathology. 74(10). 641–645. 2 indexed citations
5.
Rohr, Joseph, Yang Liu, Mingyang Li, et al.. (2020). Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets. Pathology - Research and Practice. 216(4). 152874–152874. 8 indexed citations
6.
Li, Peifeng, Mingyang Li, Kaijing Wang, et al.. (2019). Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors. Laboratory Investigation. 100(3). 426–437. 7 indexed citations
7.
Li, Mingyang, Xiaoli Su, Yingmei Wang, et al.. (2019). Lineage-negative lymphoma with a helper innate lymphoid cell phenotype. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(2). 285–293. 6 indexed citations
8.
Liu, Fang, Lu Wang, Danhui Zhao, et al.. (2019). Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. American Journal of Clinical Pathology. 152(2). 243–252. 3 indexed citations
9.
Liu, Yang, Jing Ma, Mingyang Li, et al.. (2018). Expression of programmed cell death 1/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas. Pathology - Research and Practice. 214(4). 507–512. 8 indexed citations
10.
Li, Xia, Jie Wei, Yixiong Liu, et al.. (2017). Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss. Scientific Reports. 7(1). 13038–13038. 6 indexed citations
11.
Guo, Shuangping, Xia Li, Joseph Rohr, et al.. (2016). EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features. Diagnostic Pathology. 11(1). 41–41. 38 indexed citations
12.
Zeng, Kaixuan, Zhe Wang, Koichi Ohshima, et al.. (2016). BRAFV600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis. OncoImmunology. 5(7). e1185582–e1185582. 39 indexed citations
13.
Guo, Shuangping, John K. C. Chan, Javeed Iqbal, et al.. (2014). EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations. Clinical Cancer Research. 20(12). 3078–3086. 30 indexed citations
14.
Guo, Shuangping, Qingguo Yan, Joseph Rohr, et al.. (2014). Erdheim-Chester disease involving the breast—a rare but important differential diagnosis. Human Pathology. 46(1). 159–164. 16 indexed citations
15.
Hong, Liu, John H. Zhang, Jie Min, et al.. (2010). A role for MHBst167/HBx in hepatitis B virus-induced renal tubular cell apoptosis. Nephrology Dialysis Transplantation. 25(7). 2125–2133. 17 indexed citations
16.
Ren, Li, Shuangping Guo, Xiao‐ge Zhou, & John Chan. (2009). Angiomatoid Fibrous Histiocytoma. The American Journal of Surgical Pathology. 33(10). 1570–1574. 46 indexed citations
17.
Liu, Aijun, Robert W. Allan, Zhaoli Lane, et al.. (2009). Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Modern Pathology. 22(12). 1628–1636. 57 indexed citations
18.
Guo, Shuangping, et al.. (2006). [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].. PubMed. 35(8). 467–72. 3 indexed citations
19.
Guo, Shuangping, Wenliang Wang, Wenyong Wang, & Qinglong Li. (2005). [Inhibitory effect of tumor suppressor gene PTEN on hepatocellular carcinoma cell line HHCC proliferation and its mechanisms of action].. PubMed. 27(10). 591–4. 1 indexed citations
20.
Guo, Shuangping & Wenliang Wang. (1999). Expression of HBVx gene in hepatocellular carcinoma cell and the effect on apoptosis. Experimental Pathology. 15(4). 283–286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eveline J. Kamping Breakdown of academic impact, for papers by Sung‐Im Do Breakdown of academic impact, for papers by Atif Ahmed Breakdown of academic impact, for papers by Perkins Mukunyadzi Breakdown of academic impact, for papers by Younghye Kim Breakdown of academic impact, for papers by Pierre Heimann Breakdown of academic impact, for papers by Alessia Caleo Breakdown of academic impact, for papers by Mervi Aavikko Breakdown of academic impact, for papers by Alessandra Bisagni Breakdown of academic impact, for papers by Lan L. Gellert
Rankless by CCL
2026